Alsabagh v. Takeda Pharmaceuticals America, Inc. et al

Filing 19

MDL ORDER Vacating Conditional Transfer Order and Vacating the 9/20/2012 Hearing Session Order. Signed by MDL M MDL on 8/21/2012. (Copies have been distributed pursuant to the NEF - SLR)

Case MDL No. 2299 Document 433 Filed 08/21/12 Page 1 of 1

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: ACTOS (PIOGLITAZONE) PRODUCTS
LIABILITY LITIGATION
Alsabagh v. Takeda Pharmaceuticals North America, Inc.,et al.,
D. Nevada, C.A. No. 2:12-01245

)
)

MDL No. 2299

ORDER VACATING CONDITIONAL TRANSFER ORDER,
AND VACATING THE SEPTEMBER 20, 2012, HEARING SESSION ORDER

A conditional transfer order was filed in this action (Alsabagh) on July 18, 2012. Prior to
expiration of that order’s 7-day stay of transmittal, plaintiff in Alsabagh filed a notice of opposition
to the proposed transfer. Plaintiff later filed a motion and brief to vacate the conditional transfer
order. The Panel has now been informed that, pursuant to a notice of dismissal, Alsabagh was
voluntarily dismissed in the District of Nevada by the Honorable James C. Mahan in an order filed
on August 17, 2012.
IT IS THEREFORE ORDERED that the Panel’s conditional transfer order designated as
“CTO-29” filed on July 18, 2012, is VACATED insofar as it relates to this action.
IT IS FURTHER ORDERED that the Hearing Session Order and the attached Schedule filed
on August 8, 2012, are VACATED insofar as they relate to this matter.
FOR THE PANEL:

Jeffery N. Lüthi
Clerk of the Panel